Post-transplant neurotoxicity: what role do calcineurin inhibitors actually play?
Sklar
Evelyn M
EM
D001921:Brain / Q000187:drug effects / Q000503:physiopathology; D019703:Calcineurin / Q000502:physiology; D065095:Calcineurin Inhibitors; D016572:Cyclosporine / Q000633:toxicity*; D006084:Graft Rejection / Q000276:immunology / Q000517:prevention & control*; D006801:Humans; D007166:Immunosuppressive Agents / Q000633:toxicity*; D016030:Kidney Transplantation / Q000276:immunology*; D008279:Magnetic Resonance Imaging; D020258:Neurotoxicity Syndromes / Q000209:etiology* / Q000503:physiopathology; D012307:Risk Factors; D016559:Tacrolimus / Q000633:toxicity*
D065095:Calcineurin Inhibitors; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D019703:Calcineurin; D016559:Tacrolimus